Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Moncef Slaoui in the Rose Garden on Nov. 13. Photo: Mandel Ngan/AFP via Getty Images

Moncef Slaoui, the White House's top scientific adviser to Operation Warp Speed, told Chuck Todd on "Meet the Press" on Sunday that the Trump administration's efforts to accelerate the development of a coronavirus vaccine is "isolated from a political environment" and that a change in administration "doesn't, frankly, make a difference" on its efficacy.

Why it matters: Slaoui told ABC's George Stephanopoulos on Sunday that he has not yet had contact with Joe Biden's transition team, as the president-elect prepares to inherit one of the country's biggest crises ahead of an expected vaccine distribution effort that would require massive logistical cooperation between states and the federal government.

What he's saying: When asked on "Meet the Press" if he would like to start briefing Biden's team next week, Slaoui said that he would provide public information to the new administration, but that he had "been informed that I should not be saying anything that's confidential to anybody, including anybody that's not part of the administration. And therefore, I'll act according to what the legal requirements are."

  • "As you know, I’m highly supportive of the program, and if it means I work with the new administration, I’ll be very happy to."
  • "We are concerned with anything that could derail the process. As it stands now, I can't see that happening. But, hopefully, doesn't happen," Slaoui said on ABC's "This Week," when asked if he was concerned about a lack of communication with Biden's team.

What to watch: Within 24 hours of the FDA granting an emergency use authorization to a coronavirus vaccine, Slaoui said that vaccines would be moving to state-designated storage sites.

Go deeper

21 hours ago - World

Azar's UN remarks to take aim at China

Alex Azar during a White House Coronavirus Task Force press briefing. Photo credit: Tasos Katopodis/Getty Images

Secretary of Health and Human Services Alex Azar is expected to give a speech at a special session of the United Nations General Assembly on Thursday that hails U.S. progress on coronavirus vaccines while criticizing — though not directly naming — China.

Why it matters: U.S. government officials are concerned that China will use the UN special session to spread disinformation about the origins of the virus and China's early missteps in handling the pandemic.

Pelosi, Schumer call on McConnell to adopt bipartisan $900B stimulus framework

House Speaker Nancy Pelosi on Nov. 20. Photo: Drew Angerer/Getty Images

House Speaker Nancy Pelosi (D-Calif.) and Senate Minority Leader Chuck Schumer (D-N.Y.) on Wednesday urged Senate Majority Leader Mitch McConnell (R-Ky.) to use a $908 billion bipartisan coronavirus relief framework as a basis for jumpstarting negotiations.

Why it matters: The framework, introduced by a group of bipartisan lawmakers on Tuesday, calls for significantly less funding than Pelosi had previously demanded — a sign that Democrats are ready to further compromise as millions of Americans endure economic hardship.

Bipartisan group of lawmakers unveils $908 billion COVID stimulus proposal

Sens. Joe Manchin (D-W.Va.) and Susan Collins (R-Maine) in the Capitol in 2018. Photo: Tom Williams/CQ Roll Call

A bipartisan group of lawmakers on Tuesday proposed a $908 billion coronavirus stimulus package, in one of the few concrete steps toward COVID relief made by Congress in several months.

Why it matters: Recent data shows that the economic recovery is floundering as coronavirus cases surge and hospitals threaten to be overwhelmed heading into what is likely to be a grim winter.